- Home
- BLDP vs PSNL Comparison
BLDP vs PSNL Comparison
Compare BLDP & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLDP | PSNL |
|---|---|---|
| Founded | 1979 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.0M | 746.8M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BLDP | PSNL |
|---|---|---|
| Price | $2.72 | $8.36 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | $2.24 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 3.0M | 1.4M |
| Earning Date | 11-13-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $90,252,000.00 | $69,103,000.00 |
| Revenue This Year | $40.14 | N/A |
| Revenue Next Year | $11.25 | $20.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $2.83 |
| 52 Week High | $4.10 | $11.40 |
Technical Indicators
Market Signals| Indicator | BLDP | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 49.78 | 47.89 |
| Support Level | $2.68 | $7.72 |
| Resistance Level | $2.81 | $9.74 |
| Average True Range (ATR) | 0.11 | 0.54 |
| MACD | 0.03 | 0.07 |
| Stochastic Oscillator | 67.69 | 33.66 |
Price Performance
Historical ComparisonAbout BLDP Ballard Power Systems Inc.
Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from Poland followed by United States, United Kingdom, and other countries.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.